AAAAI: Mepolizumab Can Replace Steroids in Hypereosinophilic

(6:10)

Anti IL5 and Indicators for Use

(3:55)

Mepolizumab reduces exacerbations and improves asthma control - Video abstract [ID 298559]

(3:1econd)

Welcome to the AAAAI Facebook Page.wmv

(1:46)

Frank Albers, MD, PhD: Mepolizumab COLUMBA Study Reports Consistent 3-Plus Year Benefits

(34)

AAAAI 2022 (American Academy of Allergy, Asthma and Immunology) Wrap Up Message

(2:31)

Nucala (Mepolizumab) - Asthma

(2:28)

Mepolizumab for eosinophil associated COPD: METREX and METREO - Video abstract [ID 294333]

(2:58)

AAAAI Asthma Video 1

(1:44)

Michael Wechsler, MD: Mepolizumab for eosinophilic granulomatosis with polyangiitis

(5:56)

Jonathan Spergel, MD, PhD: The Takeaways from AAAAI/WAO 18

(3:45)

AAAAI: New Findings on Immunomodulators Top Meeting Agenda

(7:3)

A (Virtual) Fireside Chat with AAAAI President Mary Beth Fasano

(47:8)

Module 5 Treatment Mepolizumab Reslizumab Benralizumab

(15:25)

The Importance of Eosinophils in Personalized Severe Asthma Treatment

(2:19)

ASL at AAAAI 2022 (American Academy of Allergy, Asthma and Immunology)

(2:20)

AAAAI: A Mouse in the House Raises Asthma Risk

(3:49)

03/05/13 Post AAAAI Meeting Review

(1:9:41)

Dr. John McKeon at AAAAI 2017

(3:20)

AAAAI \u0026 ACAAI Medical Management of Chronic Rhinosinusitis with Nasal Polyposis Guideline Highlights

(6:54)